Dr James Wylie, Consultant Clinical Oncologist

Dr James Wylie

Consultant Clinical Oncologist

Book online

Dr James Wylie MBBS, MRCP (UK), FRCR

Consultant Clinical Oncologist


Dr James Wylie

Consultant Clinical Oncologist MBBS, MRCP (UK), FRCR

Book online

Areas of expertise

  • Radiotherapy and chemotherapy for bladder and prostate cancer
  • Hormone therapy for prostate cancer
  • Soft tissue sarcoma
  • Testicular cancer
  • Urological cancers


  • HCA UK at The Wilmslow Hospital

    52-54 Alderley Road Wilmslow, London, SK9 1NY

  • The Christie Private Care

    Wilmslow Road, Manchester, M20 4BX

About Dr James Wylie

GMC number: 3497177

Year qualified: 1990

Place of primary qualification: University of London

Dr James Wylie is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust. With over 10 years of experience, he specialises in the treatment of urological cancers and sarcomas. Dr Wylie has a particular interest in prostate, bladder, and early testis cancer, employing advanced treatments such as external beam radiotherapy, brachytherapy, chemotherapy, and hormone therapy.

Dr Wylie is highly skilled in state-of-the-art radiotherapy techniques and has been instrumental in establishing and developing the prostate brachytherapy service at The Christie, which is now one of the largest in the UK. In addition to his clinical duties, he serves as an examiner for the final examination of the Royal College of Radiologists.

Dr Wylie graduated from St Thomas's Hospital Medical School in London in 1990. He trained as a Clinical Oncologist at The Christie and further honed his expertise during a Clinical Fellowship at Princess Margaret Hospital in Toronto, Canada.

His areas of expertise include:

- Radiotherapy and chemotherapy for prostate and bladder cancer
- Brachytherapy for prostate cancer and soft tissue sarcoma
- Hormone therapy for prostate cancer
- Home chemotherapy
- Intensity-Modulated Radiation Therapy (IMRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Use of advanced medications such as Enzalutamide and Abiraterone

Dr Wylie treats a range of conditions, including:

- Bladder cancer
- Prostate cancer
- Soft-tissue sarcoma
- Testicular cancer
- Teratoma
- Seminoma
- Prostate disease, including prostate cancer
- Soft tissue disorders
- Dupuytren's contracture

Dr Wylie is dedicated to providing the highest standard of care to his patients, utilising the latest advancements in oncology to achieve the best possible outcomes.

Areas of expertise

  • Radiotherapy
  • Chemotherapy
  • Bladder cancer
  • Hormone therapy
  • Prostate cancer
  • Prostate brachytherapy
  • Testis cancer
  • Soft tissue sarcoma

Professional memberships

Royal College of Physicians
Royal College of Radiologists
General Medical Council

Articles by Dr James Wylie

Does magnetic resonance imaging improve soft tissue sarcoma contouring for radiotherapy?

Multiple primary malignancies associated with a germline smarcb1 pathogenic variant

Surgical outcomes of adult patients with abdominopelvic sarcomas